https://doi.org/10.4081/itjm.2025.2015
Relationship of adiponectin levels with the severity of chronic obstructive pulmonary disease
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 22 December 2025
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and tissue damage. Adipose tissue has been identified as a contributing factor to systemic inflammation in COPD. Adiponectin is present in the airway epithelial cells and bronchoalveolar lavage fluid of patients with COPD. This suggests that adiponectin and COPD patients are related. This study aims to determine the relationship between adiponectin levels and the severity of COPD. Patients with COPD who are registered at Hasanuddin University Hospital and who fit the study’s criteria served as the subjects of this cross-sectional study. The patients who had other chronic conditions were excluded. Every patient had their adiponectin levels measured. Based on the ABE group, the severity of COPD was evaluated. Version 29.0 of SPSS was used. A total of 88 subjects were included, with 12 (13.6%) women and 76 (86.4%) men. The mean age was 64.29±9.50 years. The mean adiponectin level was 33.57±14.61. Adiponectin levels were significantly correlated with the severity of COPD (p=0.001). In conclusion, the severity of COPD decreases with increasing adiponectin levels.
Downloads
Varmaghani M, Dehghani M, Heidari E, et al. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J 2019;25:47-57. DOI: https://doi.org/10.26719/emhj.18.014
World Health Organization. Chronic obstructive pulmonary disease (COPD). Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
Nigro E, Mosella M, Daniele A, et al. Adiponectin increase in patients affected by chronic obstructive pulmonary disease with overlap of bronchiectasis. Life 2023;13:444. DOI: https://doi.org/10.3390/life13020444
Komici K, Dello IA, De Luca A, et al. Adiponectin and sarcopenia: a systematic review with meta-analysis. Front Endocrinol 2021;12:576619. DOI: https://doi.org/10.3389/fendo.2021.576619
Liu H, Tang H, Wang R, Xu J. Adiponectin antagonizes LPS-regulated secretion of inflammatory factors in airway epithelial cells, and its expression is regulated by many factors. Cell Biochem Funct 2021;39:139-47. DOI: https://doi.org/10.1002/cbf.3603
Kirdar S, Serter M, Ceylan E, et al. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand J Clin Lab Invest 2009;69:219-24. DOI: https://doi.org/10.1080/00365510802474400
Hartina S, Wahiduddin W, Rismayanti R. Faktor risiko kejadian penyakit paru obstruktif kronik pada pasien RSUD Kota Makassar. HJPH 2021;2:158-71. [Article in Indonesian]. DOI: https://doi.org/10.30597/hjph.v2i2.13139
Cosio BG, Casanova C, Soler JJ, et al. Unravelling young COPD and pre-COPD in the general population. ERJ Open Res 2023;9:0034-2022. DOI: https://doi.org/10.1183/23120541.00334-2022
Nurfitriani N, Ariesta DM. Faktor-faktor yang mempengaruhi kejadian penyakit paru obstruktif kronik (PPOK) padanpasien poliklinik paru di RSUD Meuraxa. J Sains Ris 2021;11:458-62. [Article in Indonesian].
Safitri W, Martini S, Artanti KD, Li CY. Smoking from a younger age is the dominant factor in the incidence of chronic obstructive pulmonary disease: case-control study. Int J Environ Res Pub Health 2021;18:6047. DOI: https://doi.org/10.3390/ijerph18116047
Daniele A, De Rosa A, Nigro E, et al. Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2012;44:563-9. DOI: https://doi.org/10.1016/j.biocel.2011.12.016
Jaswal S, Saini V, Kaur J, et al. Association of adiponectin with lung function impairment and disease severity in chronic obstructive pulmonary diseases. Int J App Basic Med Res 2017;8:14-8. DOI: https://doi.org/10.4103/ijabmr.IJABMR_65_17
Lin YH, Jiang TX, Hu SX, Shi YH. Association between serum adiponectin concentrations and chronic obstructive pulmonary disease: a meta-analysis. Biosci Rep 2020;40:BSR20192234. DOI: https://doi.org/10.1042/BSR20192234
Ouchi N, Walsh K. A novel role for adiponectin in the regulation of inflammation. Arterioscler Thromb Casc Biol 2008;28:1219-21. DOI: https://doi.org/10.1161/ATVBAHA.108.165068
Yoon HI, Li Y, Man S, Tashkin D, et al. The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin. Chest 2012;142:893-9. DOI: https://doi.org/10.1378/chest.11-2173
Sanduzzi A, Balbo P, Candoli P, et al. COPD: adherence to therapy. Multidis Resp Med 2014;9:60. DOI: https://doi.org/10.4081/mrm.2014.395
Kampani G, Singh P, Khan A. Study of adiponectin and leptin levels in patients of COPD and its correlation with severity and acute exacerbation of disease. JIACM 2020;21:39-42.
Mohamed NA, Fawzy MA, Elgamry R, et al. Role of adiponectin and other inflammatory biomarkers in COPD patients. Egypt J Chest Dis Tub 2013;62:45-50. DOI: https://doi.org/10.1016/j.ejcdt.2013.03.005
Ariyani DR, Sarbini D, Yuliati R. Hubungan antara status gizi dan pola makan dengan fungsi paru pada pasien penyakit paru obstruktif kronik (PPOK) di balai besar kesehatan paru Masyarakat Surakarta. Pros Sem Nas. 2013. Available from: https://eprints.ums.ac.id/12540/. [Thesis in Indonesian].
Oemiati R. Kajian epidemiologis penyakit paru obstruktif kronik (PPOK). Media Litbangkes 2023;23:82-8. [Article in Indonesian].
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.